Immunolocalization of P2Y1 and TPα receptors in platelets showed a major pool associated with the membranes of α-granules and the open canalicular system
Open Access
- 15 February 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (4) , 1400-1408
- https://doi.org/10.1182/blood-2002-02-0642
Abstract
P2Y1 and thromboxane-prostanoid–α (TPα) receptors on platelets belong to the G-protein–coupled 7–transmembrane domain family. They transmit signals for shape change, mobilization of calcium, and platelet aggregation. Immunogold labeling with a monoclonal antibody (MoAb) to the amino-terminal domain of P2Y1 and a polyclonal antibody to the C-terminal domain of TPα revealed that while present at the platelet surface, both receptors were abundantly represented inside the platelet. Specifically, receptors were found in membranes of α-granules and elements of the open-canalicular system. A similar organization was found in mature megakaryocytes. Activation of platelets by adenosine diphosphate (ADP) and the thromboxane A2(TXA2) analog, I-BOP [1S-(1 α,2 β(5Z),3 α-(1E,3S)4 α)-7-(3-(3- hydroxy-4-(p-iodophenoxy)-1-butenyl)-7-oxabicyclo(2.2.1)hept-2-yl)-5-heptenoic acid], increased the labeling of both P2Y1 and TPα at the surface and in intracellular pools, suggesting that activation resulted in greater antibody accessibility to the receptor. A return to a platelet discoid shape and to basal values of labeling accompanied receptor desensitization. Platelets lacking the P2Y12 ADP receptor normally expressed P2Y1 and TPα, both before and after activation. Studies with the anti–ligand-induced binding site (anti-LIBS) MoAb, AP-6, confirmed that stored fibrinogen associated with internal pools of αIIbβ3 at the start of secretion in a microenvironment containing agonist receptors. Pharmacologic antagonism of ADP or TXA2 receptors in antithrombotic therapy may need to take into account blockade of internal receptor pools.Keywords
This publication has 39 references indexed in Scilit:
- P2Y12, a New Platelet ADP Receptor, Target of ClopidogrelBiochemical and Biophysical Research Communications, 2001
- Thromboxane A2 receptors: where have you gone?☆Prostaglandins & Other Lipid Mediators, 2000
- Phosphorylation of the Thromboxane Receptor α, the Predominant Isoform Expressed in Human PlateletsPublished by Elsevier ,1999
- Subcellular Localization of α-Subunits of Trimeric G-Proteins in Human PlateletsBiochemical and Biophysical Research Communications, 1997
- Thrombin Receptors on Human PlateletsJournal of Biological Chemistry, 1997
- G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestinsCanadian Journal of Physiology and Pharmacology, 1996
- Trafficking thrombin receptorsTrends in Cardiovascular Medicine, 1995
- An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function.Journal of Clinical Investigation, 1995
- Mouse thromboxane A2 receptor: cDNA cloning, expression and Northern blot analysisBiochemical and Biophysical Research Communications, 1992
- Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.Journal of Clinical Investigation, 1989